首页> 外文期刊>Analytical chemistry >Matrix Effect in Quantitative LC/MS/MS Analyses of Biological Fluids: A Method for Determination of Finasteride in Human Plasma at Picogram Per Milliliter Concentrations
【24h】

Matrix Effect in Quantitative LC/MS/MS Analyses of Biological Fluids: A Method for Determination of Finasteride in Human Plasma at Picogram Per Milliliter Concentrations

机译:LC / MS / MS定量分析生物流体中的基质效应:以每毫升皮克浓度测定人血浆中非那雄胺的方法

获取原文
获取原文并翻译 | 示例
           

摘要

Contrary to common perceptions, the reliability of quantitative assays for the determination of drugs in biological fluids using high-performance liquid chromatography with tandem mass spectrometric (LC/MS/MS) detection methods and the integrity of resulting pharmacokinetic data may not be absolute. Results may be adversely affected by lack of specificity and selectivity due to ion suppression caused by the sample matrix, interferences from metabolites, and "cross-talk" effects. In this paper, an example of the effect of the sample matrix on the determination of finasteride (I) in human plasma is presented. The ion suppression effect was studied by analyzing standards of I injected directly in mobile phase and comparing the response (peak areas) of I and an internal standard (II) with the peak areas of the same analytes spiked before extraction into five different plasma pools and standards spiked into the plasma extracts after extraction. The LC/ MS/MS analyses were performed using a turbo ion spray interface (TISP) under chromatographic conditions, characterized by minimal (total run time of 2 rain, capacity factors, k of 1.50 and 1.75 for I and II, respectively) and high retention of the analytes (total run time 6 min k of 3.25 and 13.25 for I and II, respectively). The absolute peak areas for Ⅰ and Ⅱ in different plasmas were calculated, and the slopes and peak area ratios at all concentrations within the standard curve ranges were compared. When analyses were performed under conditions of minimal HPLC retention, the slope of the standard line for one set of plasma samples was substantially different (about 50% higher) from that from other plasma sources. The precision of the assay, expressed as coefficient of variation (CV, %) was also inadequate and varied from 15 to 30% at an concentrations within the standard curve range. When the same experiments were repeated using high HPLC retention, the slopes from different plasma sources were practically the same, and the CV was improved to 6-14%. By increasing k’ and providing more chromatographic retention of analytes, the "unseen" interferences from plasma matrix were mostly separated from analytes, practically eliminating the ion suppression. In addition, by eliminating from plasma extracts a number of endogenous components through more selective extraction, the ion suppression was also minimized. The detailed data and the design of these experiments are presented. In addition, development of a highly sensitive assay for I in human plasma at low picogram pre milliliter concentrations using LC/MS/MS with a heated nebulizer (HN) interface, instead of a TISP interface, is described. In this case, the effects of sample matrixes were not observed.
机译:与通常的看法相反,使用高效液相色谱-串联质谱(LC / MS / MS)检测方法进行生物液体中药物测定的定量分析的可靠性以及所得药代动力学数据的完整性可能不是绝对的。由于样品基质引起的离子抑制,代谢物的干扰和“串扰”效应,特异性和选择性不足会不利地影响结果。本文以样品基质对人血浆中非那雄胺(I)测定的影响为例。通过分析直接注入流动相中的I的标准品,并将I和内标(II)的响应(峰面积)与萃取到五个不同血浆池中的相同分析物的峰面积进行比较,研究了离子抑制效果。提取后将标准品加到血浆提取物中。 LC / MS / MS分析是在色谱条件下使用涡轮离子喷雾接口(TISP)进行的,其特征是最小(总运行时间为2雨,容量因子,I和II的k分别为1.50和1.75)和高保留分析物(I和II的总运行时间6 min k分别为3.25和13.25)。计算了不同血浆中Ⅰ和Ⅱ的绝对峰面积,并比较了标准曲线范围内所有浓度下的斜率和峰面积比。在最小的HPLC保留条件下进行分析时,一组血浆样品的标准线斜率与其他血浆来源的斜率有很大不同(约高50%)。以变​​异系数(CV,%)表示的测定精度也不足,在标准曲线范围内的浓度范围内为15%至30%。使用高HPLC保留率重复进行相同的实验时,来自不同血浆来源的斜率实际上是相同的,并且CV提高到6-14%。通过增加k'并提供更大的分析物色谱保留率,血浆基质中“看不见的”干扰物大部分与分析物分离,实际上消除了离子抑制作用。另外,通过从血浆中提取出更多选择性提取的内源性成分,离子抑制也得以最小化。介绍了这些实验的详细数据和设计。此外,还描述了使用具有加热的雾化器(HN)接口而不是TISP接口的LC / MS / MS在低皮克级前毫升浓度下对人血浆中I的高灵敏度测定方法的开发。在这种情况下,未观察到样品基质的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号